Somaxon prices underwritten public offering of common stock

NewsGuard 100/100 Score
Editorial Checklist Reviewed
Nov 19 2010Somaxon Pharmaceuticals, Inc.

Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX) today announced that it has priced an underwritten public offering of 8,800,000 shares of its common stock at a price to the public of $2.95 per share. The offering is expected to close on or about November 24, 2010, subject to customary closing conditions.

Piper Jaffray & Co. is acting as sole underwriter for the offering. Somaxon has granted the underwriter a 30-day option to purchase up to 1,320,000 additional shares of common stock to cover over-allotments, if any.

Source:

Somaxon Pharmaceuticals, Inc.

Posted in:

Tags: , , ,

Comments (0)

Suggested Reading

Pembrolizumab enhances breast cancer treatment regardless of age or menopausal status
Sensing a Healthier Future with Sustainable Nanomaterials and Biosensors
Georgetown study raises concerns over aspirin's role in breast cancer treatment
New urine-based test improves identification of high-grade prostate cancer
Extended CPAP treatment boosts lung development in premature infants
Lancet Commission predicts sharp increase in global prostate cancer cases
Common HIV drugs linked to reduced Alzheimer's disease risk
Natural obesity fighters: How coffee, tea, and cocoa combat weight gain

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Research quantifies impact of childhood obesity on long-term health and life expectancy